Cargando…

Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer Aged at Least 75 Years: A Post-Hoc Subgroup Analysis of Three Phase II Trials

Patients older than 75 years of age are usually excluded from metastatic colorectal cancer studies based on a combination chemotherapy containing oxaliplatin. Our group conducted three phase II trials in elderly patients in recent years. A post-hoc subgroup analysis of 67 patients aged at least 75 y...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosati, Gerardo, Cordio, Stefano, Reggiardo, Giorgio, Aprile, Giuseppe, Butera, Alfredo, Avallone, Antonio, Tucci, Aniello, Novello, Giuseppe, Blanco, Giuseppina, Caputo, Giuseppe, Bilancia, Domenico, Bordonaro, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521155/ https://www.ncbi.nlm.nih.gov/pubmed/31022922 http://dx.doi.org/10.3390/cancers11040578

Ejemplares similares

Colorectal Cancer Heterogeneity and the Impact on Precision Medicine and Therapy Efficacy
por: Rosati, Gerardo, et al.
Publicado: (2022)

Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy
por: Fanotto, Valentina, et al.
Publicado: (2018)

Perspectives in the Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer Patients
por: Rosati, Gerardo, et al.
Publicado: (2021)

Capecitabine and oxaliplatin combined with bevacizumab are feasible for treating selected Japanese patients at least 75 years of age with metastatic colorectal cancer
por: Munemoto, Yoshinori, et al.
Publicado: (2015)

HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives
por: Fanotto, Valentina, et al.
Publicado: (2016)

Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer: A Randomized Clinical Trial
por: Avallone, Antonio, et al.
Publicado: (2021)

Role of oxaliplatin in the treatment of colorectal cancer
por: Comella, Pasquale, et al.
Publicado: (2009)

An Update on the Role of Anti-EGFR in the Treatment of Older Patients with Metastatic Colorectal Cancer
por: Rosati, Gerardo, et al.
Publicado: (2022)

Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4
por: Borghi, Claudio, et al.
Publicado: (2013)

Timing and extent of response in colorectal cancer: critical review of current data and implication for future trials
por: Aprile, Giuseppe, et al.
Publicado: (2015)

The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials
por: Schulman, Gerald, et al.
Publicado: (2016)

Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO
por: Rossini, Daniele, et al.
Publicado: (2022)

Testing If Primal World Beliefs Reflect Experiences—Or at Least Some Experiences Identified ad hoc
por: Clifton, Jeremy D. W.
Publicado: (2020)

A non-stationary Markov model for economic evaluation of grass pollen allergoid immunotherapy
por: Bilancia, Massimo, et al.
Publicado: (2020)

White-Coat Hypertension: the Neglected Subgroup in Hypertension
por: Cuspidi, Cesare, et al.
Publicado: (2018)

Factors impacting the efficacy of venlafaxine extended release 75–225 mg/day in patients with major depressive disorder: exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study in Japan
por: Watanabe, Yoshinori, et al.
Publicado: (2018)

Unexpected and durable response with regorafenib in a metastatic colorectal cancer patient without KDR mutation: A case report
por: Rosati, Gerardo, et al.
Publicado: (2018)

Formoterol as reliever medication in asthma: a post-hoc analysis of the subgroup of the RELIEF study in East Asia
por: Cheng, Qi Jian, et al.
Publicado: (2016)

Benefit with preventive noninvasive ventilation in subgroups of patients at high-risk for reintubation: a post hoc analysis
por: Hernández, Gonzalo, et al.
Publicado: (2022)

Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer
por: Cardone, Claudia, et al.
Publicado: (2019)

Historia de la filosofía hindú
por: Tucci, giuseppe
Publicado: (1974)

Effectiveness of Tiotropium/Olodaterol in the Real World: A Post Hoc Subgroup Analysis After the First Year of Use
por: Sato, Atsuyasu, et al.
Publicado: (2022)

Efficacy and safety of anamorelin in patients with cancer cachexia: Post‐hoc subgroup analyses of a placebo‐controlled study
por: Takayama, Koichi, et al.
Publicado: (2022)

The Spectrum of Response to Erenumab in Patients With Episodic Migraine and Subgroup Analysis of Patients Achieving ≥50%, ≥75%, and 100% Response
por: Broessner, Gregor, et al.
Publicado: (2020)

Intracranial mesenchymal tumors with FET‐CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas
por: Sloan, Emily A., et al.
Publicado: (2021)

Adding Humic Acids to Gelatin Hydrogels: A Way to Tune Gelation
por: Venezia, Virginia, et al.
Publicado: (2021)

Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc?
por: Baronti, Arianna, et al.
Publicado: (2022)

Role of MicroRNAs in the Development and Progression of the Four Medulloblastoma Subgroups
por: Bevacqua, Emilia, et al.
Publicado: (2021)

Editorial: Ad-Hoc Selection of Lactic Acid Bacteria for Non-conventional Food Matrices Fermentations: Agri-Food Perspectives
por: Pontonio, Erica, et al.
Publicado: (2021)

Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: a WhatsApp messenger-based report from the Italian College of Chief Medical Oncologists
por: Blasi, Livio, et al.
Publicado: (2020)

Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial
por: Tashkin, Donald P., et al.
Publicado: (2018)

Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analyses
por: Coghill, David R., et al.
Publicado: (2020)

Post Hoc Subgroup Analysis of the BCause Study Assessing the Effect of AbobotulinumtoxinA on Post-Stroke Shoulder Pain in Adults
por: Riberto, Marcelo, et al.
Publicado: (2022)

Inference on subgroups identified based on a heterogeneous treatment effect in a post hoc analysis of a clinical trial
por: Zhao, Beibo, et al.
Publicado: (2023)

Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial
por: Auclin, Edouard, et al.
Publicado: (2019)

Molecular Subgroup Analysis of Clinical Outcomes in a Phase 3 Study of Gemcitabine and Oxaliplatin with or without Erlotinib in Advanced Biliary Tract Cancer
por: Kim, Seung Tae, et al.
Publicado: (2015)

A fast on-line event reconstruction procedure based on a linearized least-squares fit
por: Aprile, E, et al.
Publicado: (1981)

Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS-mutated metastatic colorectal cancer: the REVOLUTION study protocol
por: Avallone, Antonio, et al.
Publicado: (2020)

Oxaliplatin in practice.
por: Misset, J. L.
Publicado: (1998)

Efficacy of adalimumab across subgroups of patients with moderate-to-severe chronic plaque psoriasis of the hands and/or feet: post hoc analysis of REACH
por: Poulin, Y, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8hjao4fek4u6c03lvuntplmfk4